| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -5.5e-05 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 3.8e-05 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -3.7e-05 | 1 |